|
|
|
Medicines Transparency Alliance (MeTA)
|
During 2007, the United Kingdom Department for International Development (DfID), in partnership with WHO and other
international agencies, has been developing the Medicines Transparency Alliance (MeTA) – an international
multi-stakeholder alliance to promote transparency in the supply of essential medicines, with the aim of improving
access to affordable essential drugs in developing countries. MeTA’s focus will be on the collection, analysis,
dissemination and use of data on medicine quality, availability, affordability, and access. This will help
improve transparency in the way medicines are procured, distributed, and supplied to consumers and patients. It
is expected that MeTA will be comprised of 3 major components: country level pilot projects, global public health
goods, and an academic research observatory. Dennis Ross-Degnan and Brenda Waning from the CCPP have been actively
engaged with MeTA at country and global level to assist in the design and implementation of MeTA.
Planned CCPP activities under MeTA include:
- Continued assessment of prices of medicines purchased through the Global Fund and other global initiatives
- Development, testing, and implementation of an assessment framework to evaluate the impacts of MeTA over time
- Contribution of methods and tools to the global repository of information on medicines
- Technical assistance to MeTA country projects which will likely focus on medicines price, quality, and affordability
|
|
LATEST UPDATES
MedIC
Initiative Courses conducted in Accra, Ghana
, November 16-25, 2008 and in Beijing, China, March 22-31, 2009
|
